Trial · NCT02737826
Results by group25
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 25
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Patients Who Tolerate Buprenorphine Initiation | Phase I - Buprenorphine Initiation | 27 | Participants | ||
| Number of Participants Who Achieve Opioid Cessation | Phase II - Gabapentin + Buprenorphine Taper | 1 | Participants | ||
| Number of Participants Who Achieve Opioid Cessation | Phase II - Placebo + Buprenorphine Taper | 0 | Participants | ||
| Number of Participants Who Achieve Opioid Cessation Post-taper: 1 Month | Gabapentin + Buprenorphine Taper - Opioid Cessation 1 Month Post-taper | 0 | Participants | ||
| Number of Participants Who Achieve Opioid Cessation Post-taper: 1 Month | Placebo + Buprenorphine Taper - Opioid Cessation 1 Month Post-taper | 0 | Participants | ||
| Pain Self-report: Pain Catastrophizing Scale - Baseline | Gabapentin + Buprenorphine Taper | 21.9 | Full Range 3 to 39 | units on a scale | |
| Pain Self-report: Pain Catastrophizing Scale - Baseline | Placebo + Buprenorphine Taper | 21.2 | Full Range 0 to 48 | units on a scale | |
| Pain Laboratory Testing: Mechanical - Baseline | Gabapentin + Buprenorphine Taper | 284.2 | Full Range 113.7 to 482.7 | grams per second | |
| Pain Laboratory Testing: Mechanical - Baseline | Placebo + Buprenorphine Taper | 289.1 | Full Range 163.6 to 627.3 | grams per second | |
| Mean Score of Current Opioid Measure (COMM) | Gabapentin + Buprenorphine Taper | 16 | Full Range 1 to 41 | units on a scale | |
| Mean Score of Current Opioid Measure (COMM) | Placebo + Buprenorphine Taper | 15 | Full Range 5 to 49 | units on a scale | |
| Mean Score of PROMIS Physical Function Short Form (PROMIS SF 10) - RAW SCORE PH | Gabapentin + Buprenorphine Taper | 10.3 | Full Range 8 to 14 | units on a scale | |
| Mean Score of PROMIS Physical Function Short Form (PROMIS SF 10) - RAW SCORE PH | Placebo + Buprenorphine Taper | 11 | Full Range 7 to 14 | units on a scale | |
| Mean Score Pittsburgh Sleep Quality Index | Gabapentin + Buprenorphine Taper | 12.5 | Full Range 4 to 19 | units on a scale | |
| Mean Score Pittsburgh Sleep Quality Index | Placebo + Buprenorphine Taper | 10.6 | Full Range 4 to 16 | units on a scale | |
| Mean Score of Subjective Opioid Withdrawal Scale (SOWS) | Gabapentin + Buprenorphine Taper | 17.3 | Full Range 0 to 58 | units on a scale | |
| Mean Score of Subjective Opioid Withdrawal Scale (SOWS) | Placebo + Buprenorphine Taper | 11.9 | Full Range 0 to 49 | units on a scale | |
| Number of Participants Who Achieved Opioid Cessation Post-taper - 3 Months | Gabapentin + Buprenorphine Taper - Opioid Cessation 3 Months Post-taper | 1 | Participants | ||
| Number of Participants Who Achieved Opioid Cessation Post-taper - 3 Months | Placebo + Buprenorphine Taper - Opioid Cessation 3 Months Post-taper | 0 | Participants | ||
| Number of Participants Who Achieved Opioid Cessation Post-taper - 6 Months | Gabapentin + Buprenorphine Taper - Opioid Cessation 6 Months Post-taper | 1 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02737826/results